๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Overweight , Obesity
Clinical trial register · China

Overweight , Obesity Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5 Luoyang 3 Chengdu 3 Guangzhou 3 Shanghai 3
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5 Luoyang3 Chengdu3 Guangzhou3 Shanghai3
All 29 locations
Target enrolment
to

Overweight , Obesity trials in China

21 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
NCT07807059Overweight/Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH), Type 2 Diabetes Mellitus
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
32
Chengdu
2026-09-09
Not yet open
Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity
NCT07778693Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 3
760
Beijing
2026-09-01
Not yet open
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
NCT07798284Overweight/Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Wuhan, Xianning, Jinan, Shanghai, Luzhou
2026-09
Not yet open
Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants
NCT07779980Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
103
Kunming
2026-08-26
Not yet open
A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults
NCT07697846Overweight, Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Beijing
2026-07-18
Recruiting
Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity
NCT07331974Overweight , Obesity
Moon (Guangzhou) Biotechnology Co., Ltd.
Not applicable
200
Guangzhou
2026-07-01
Not yet open
Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
NCT07485764Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis, Overweight , Obesity
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
186
Wuhan
2026-06
Recruiting
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants
NCT07550816Overweight,Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
60
Chengdu
2026-05-27
Not yet open
Effects of High-frequency Left Dorsolateral Prefrontal rTMS on Heart-brain Coupling in Women With Recurrent Pregnancy Loss and Elevated BMI
NCT07561931Recurrent Pregnancy Loss, Overweight , Obesity, Heart-Brain Coupling
Shenyang Medical College
Not applicable
60
Shenyang
2026-04-28
Recruiting
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
NCT07803809Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM), MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
36
Kunming
2026-04-26
Recruiting
A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
NCT07443059Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Xiamen, Jinan, Chengdu
2026-04-13
Recruiting
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
NCT07372729Prehypertension, Borderline Dyslipidemia, Overweight , Obesity, Prediabetes
Beijing Anzhen Hospital
Not applicable
1,400
Beijing, Cangzhou, Yuhuan
2026-03-24
Active, closed
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity
NCT07804797Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 2
71
Luoyang
2026-03-02
Recruiting
MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
NCT07505745Prediabetes, Insulin Resistance, Overweight/Obesity
Hudson Biotech
Phase 2
120
Shenzhen
2026-02-02
Active, closed
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
NCT07230119Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 3
755
Xuancheng, Beijing, Chongqing, Lanzhou, Guangzhou, Huizhou, Nanning, Handan
2026-01-16
Active, closed
Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight
NCT07791537Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 2
125
Luoyang
2025-12-26
Recruiting
Bioequivalence Study of BGM0504 Injection
NCT07382908Overweight/Obesity
BrightGene Bio-Medical Technology Co., Ltd.
Phase 1
144
Hangzhou
2025-12-23
Active, closed
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 2
184
Handan, Langfang, Harbin, Luoyang, Chenzhou, Yueyang, Nanjing, Jinan
2025-12-12
Recruiting
Asiaticoside for Treating Overweight/Obesity
NCT07241533Overweight , Obesity
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2025-12-01
Recruiting
Effect of Low Valine Diet on Body Weight and Metabolic Parameters
NCT06883578Overweight/obesity, Metabolic Associated Fatty Liver Disease, Metabolic Diseases
Shanghai Zhongshan Hospital
Not applicable
48
Shanghai
2025-02-18
Active, closed
Study on the Efficacy of Probiotics in the Treatment of Childhood Obesity and Their Effects on Gut Microbiota
NCT07448220Overweight , Obesity
Min-Tze LIONG
Phase 2
60
Jiading
2023-12-01
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/overweight-obesity

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies listing the condition Overweight , Obesity.

How many Overweight , Obesity trials are recruiting in China?

10 of the 21 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Overweight , Obesity), 21 studies
PhaseStudiesRecruitingShare
Phase 18538.1%
Not applicable5423.8%
Phase 25123.8%
Phase 3209.5%
Phase 4104.8%

Most active sponsors

Lead sponsors with the most studies (Overweight , Obesity)
Lead sponsorStudiesRecruiting
Beijing QL Biopharmaceutical Co.,Ltd52
Shanghai Minwei Biotechnology Co., Ltd51
Shanghai Zhongshan Hospital22
Beijing Anzhen Hospital11
BrightGene Bio-Medical Technology Co., Ltd.11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10
Fujian Shengdi Pharmaceutical Co., Ltd.11
Hudson Biotech11
Min-Tze LIONG10
Moon (Guangzhou) Biotechnology Co., Ltd.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.